Pacific Biosciences of California, Inc. (PACB) Earnings Per Share (EPS)
Pacific Biosciences of California, Inc. (PACB) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$0.55 |
| 2020-12-31 | $0.18 |
| 2021-12-31 | -$0.89 |
| 2022-12-31 | -$1.40 |
| 2023-12-31 | -$1.21 |
| 2024-12-31 | -$1.13 |
| 2025-12-31 | -$1.82 |
How PACB compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| RFL | Rafael Holdings Inc. Class B | -$1.04 |
| IOVA | Iovance Biotherapeutics Inc. | -$1.09 |
| ALEC | Alector Inc. | -$1.39 |
| RLMD | Relmada Therapeutics Inc. | -$1.45 |
| INO | Inovio Pharmaceuticals Inc. | -$1.81 |
These are five companies in the same sector as PACB with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Pacific Biosciences of California, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("PACB")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PACB | $1.28 | -5.54% | 6.03M |
| 3 | ||||
| 4 | ||||
| 5 |